Led by researchers at RCSI (Royal College of Surgeons in Ireland), a team of researchers has developed a new treatment for tuberculosis (TB). This work could offer a practical treatment that has the potential to be scaled-up and mass-produced for clinical testing.
The treatment, which patients will take using an inhaler, works by reducing the bacteria in the lungs that causes tuberculosis while also helping the patient’s immune system fight the disease.
There is only one vaccine for tuberculosis, developed in 1921. It is unreliable in preventing the most common form of TB, and is not suitable in all patient groups. The vaccine works best against specific forms of TB and is usually given to infants in at-risk populations.
Tuberculosis is one of the top 10 causes of death worldwide. The World Health Organization (WHO) data show that 10 million people fell ill with TB and 1.6 million died from the disease in 2017. WHO estimates that there were 558,000 new cases with resistance to the most effective first-line antibiotic. Of those resistant to the drug, 82% were resistant to multiple antibiotics.
Funded by the Health Research Board (HRB) and the Royal City of Dublin Hospital Trust, the research is published in the European Journal of Pharmaceutics & Biopharmaceutics.
The work, led by Dr Gemma O’Connor and Prof Sally-Ann Cryan in RCSI, was carried out in collaboration with research teams in St James Hospital, Trinity College Dublin and Imperial College London. Prof Joseph Keane and Dr Mary O’Sullivan led the team at St James Hospital and Trinity College Dublin with Dr Brian Robertson and Dr Nitya Krishnan leading the team at Imperial College London.
Multidrug-resistant TB (MDR-TB) is seen as both a public health crisis and a health security threat. Ending the TB epidemic by 2030 is listed among the health targets of the United Nations Sustainable Development Goals.
The pathogen that causes tuberculosis spreads by people breathing infected droplets into their lungs, where the disease can remain dormant or spread further. The research makes use of a derivative of Vitamin A called all trans retinoic acid, atRA, which previous studies have shown is an effective treatment for tuberculosis.
“Many cases of TB are now becoming resistant to existing antibiotics. This new treatment could be used alongside antibiotics to treat drug-resistant TB and also possibly reduce the rate of antibiotic resistance resulting from conventional antibiotic treatments,” said Prof Cryan, Associate Professor of Pharmaceutics in RCSI School of Pharmacy and the study’s senior author.
Using a spray-drying process, the researchers packaged atRA within safe-for-consumption particles that are small enough to use in an inhaler. These particles efficiently delivered the treatment and significantly reduced tuberculosis-causing bacteria and associated lung damage, which supports their potential for clinical testing.
“Unfortunately, tuberculosis remains a significant problem for world health. We urgently need innovative treatments like this one if we are to achieve the UN 2030 health targets,” said Prof Keane, Professor at Trinity College Dublin School of Medicine and Consultant Respiratory Physician in St James’s Hospital.
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- What you need to know about pulmonary Tuberculosison November 18, 2019 at 7:10 pm
COLUMBIA, S.C. — Lexington Medical Center has confirmed that both the hospital and the South Carolina Department of Health have completed initial testing on anyone who may have encountered a patient ...
- CDC answers call for accountability in global tuberculosis responseon November 18, 2019 at 2:00 pm
They also found that Mpilo had tuberculosis (TB) — a potentially deadly combination. Doctors started Mpilo and his sister on a daily regimen of HIV antiretrovirals and immediately began TB treatment ...
- New clinical guideline for the treatment and prevention of drug-resistant tuberculosison November 18, 2019 at 7:24 am
The American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society and the Infectious Diseases Society of America have published an official clinical guideline on ...
- New research into badger dispersal could minimize bovine tuberculosis spreadon November 18, 2019 at 6:06 am
Zoology researchers from Trinity, working with the Department of Agriculture, Food and The Marine (DAFM) and the National Parks and Wildlife Service (NPWS), have unlocked the secrets of dispersing ...
- BCG Tuberculosis (TB) Vaccine Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 – 2025on November 18, 2019 at 2:37 am
WiseGuyRerports.com Presents “Global BCG Tuberculosis (TB) Vaccine Market Size, Status and Forecast 2019-2025” New Document to its Studies Database The global BCG Tuberculosis (TB) Vaccine market, as ...
- Three Cases of Tuberculosis Reported: Countyon November 15, 2019 at 11:10 pm
The County Health and Human Services Agency (HHSA) notified San Diego County residents of three unrelated cases of tuberculosis on Thursday. Two of the cases were reported at San Diego County ...
- Elephants at Tacoma zoo with tuberculosis won’t be treatedon November 15, 2019 at 3:03 am
TACOMA, Wash. — The two Asian elephants at Point Defiance Zoo & Aquarium have tested positive for tuberculosis, according to zoo officials. Head zoo veterinarian Dr. Karen Wolf said elephants Hanako ...
- BCG Tuberculosis (TB) Vaccine Market is Booming Worldwideon November 14, 2019 at 12:48 am
Nov 14, 2019 (Market Prediction via COMTEX) -- The latest trending report Global BCG Tuberculosis (TB) Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2026 offered by ...
- Auburn hospital says 26 infants, 27 adult patients possibly exposed to tuberculosison November 13, 2019 at 11:11 am
Officials at a hospital in Auburn said they are contacting 27 adult patients and the families of 26 infants to recommend testing for tuberculosis. The recommendation also extends to visitors who had ...
- Hospital says 26 infants, 27 adult patients possibly exposed to tuberculosison November 13, 2019 at 11:06 am
Related Video: Medical Officer Discusses Tuberculosis Exposure at Hospital in Auburn, Wash. (Provided by KING-TV Seattle) Officials at a hospital in Auburn, Wash., said they are contacting 27 adult ...
via Bing News